Shattuck Labs (STTK) Depreciation and Depletion (2019 - 2026)
Shattuck Labs (STTK) reported Depreciation and Depletion of $891000.0 for Q1 2026, down 4.81% year-over-year from $936000.0 in Q1 2025, and down 1.66% quarter-over-quarter from $906000.0 in Q4 2025.
Shattuck Labs (STTK) Depreciation and Depletion (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Depreciation and Depletion data on file, last reported at $891000.0 in Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $891000.0, down 4.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (down 2.15% YoY), and the FY2025 annual result was $3.7 million, down 3.68% from the prior year.
- Depreciation and Depletion retreated to $891000.0 in Q1 2026 per STTK's latest filing, from $906000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $1.0 million in Q2 2023 and troughed at $472000.0 in Q1 2022.
- A 5-year average of $903647.1 and a median of $934000.0 in 2022 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2022 and 2024: Depreciation and Depletion soared 145.79% in 2022, then fell 12.37% in 2024.
- A 5-year view of Depreciation and Depletion shows it stood at $1.0 million in 2022, then fell by 2.39% to $981000.0 in 2023, then slipped by 4.18% to $940000.0 in 2024, then retreated by 3.62% to $906000.0 in 2025, then retreated by 1.66% to $891000.0 in 2026.
- Business Quant data shows STTK's Depreciation and Depletion at $891000.0 in Q1 2026, $906000.0 in Q4 2025, and $900000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 891,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 891,000.00 |
| Mar 31, 2026 | 891,000.00 |
| Dec 31, 2025 | 906,000.00 |
| Dec 31, 2025 | 906,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2025 | 936,000.00 |
| Mar 31, 2025 | 936,000.00 |
| Dec 31, 2024 | 940,000.00 |
| Dec 31, 2024 | 940,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 974,000.00 |
| Mar 31, 2024 | 974,000.00 |
| Dec 31, 2023 | 981,000.00 |
| Dec 31, 2023 | 981,000.00 |